An analysis of an unusual enzyme could result in a new generation of antimicrobial medicines to counter antibiotic resistance. Key details in the enzyme-driven biosynthesis of a natural molecule with ...

Researchers have developed a microrobotic drug delivery system that is simple and biocompatible, using it successfully in ...

Scientists finally identify why statins can cause the 'painful' side effect in some people ...

Findings from the LEAP2MONO study support the regulatory submission of venglustat for treatment of type 3 Gaucher disease.

A hydrogel made from crustacean shells lets common food bacteria generate electrical signals 15 times more efficiently, opening the door to reusable living sensors for food safety.

About Chiesi Group Chiesi is a research-oriented international biopharmaceutical group that develops and markets innovative ...

In November 2023, the UK became the first country in the world to authorise a Crispr gene-editing therapy.

Biochemistry Professor Andy LiWang may have uncovered a universal mechanism that explains how bacteria, and potentially many ...

A new in vivo pharmacokinetic recall study involving 114 participants in the Estonian Biobank has provided the first clinical confirmation that previously uncharacterized genetic variants in the ...

Every time a cell divides, it must copy its entire genome so that each daughter cell inherits a complete set of DNA. During that process, enzymes known as polymerases race along the DNA to copy its ...